Sucralet Tablet

About Sucralet 500 mg Tablet

Sucralet 500 mg Tablet is a sucralfate medicine used to treat stomach and duodenal ulcers and chronic gastritis, and to help prevent bleeding from stress ulcers in seriously ill patients. It works in the gut rather than through the whole body.

There are 15 brands of Sucralfate listed in Bangladesh. The lowest listed price is Antepsin 1000 mg Tablet at ৳ 5.52 per unit.

What is Sucralet 500 mg Tablet?

Sucralet 500 mg Tablet is a sucralfate preparation made by National Laboratories Ltd. Sucralfate is a chelating complex that is only minimally absorbed from the gastrointestinal tract. It forms a chemical complex that binds to the ulcer site and creates a protective barrier, which supports healing of gastric and duodenal ulcers. It also reduces the action of pepsin and bile. Because so little is absorbed, most of the medicine stays in the gut. The doctor decides the dose and course for each person.

Uses of Sucralet

Sucralet 500 mg Tablet is used in adults and adolescents for duodenal ulcer, gastric ulcer and chronic gastritis. It is also used to help prevent gastrointestinal bleeding caused by stress ulceration in patients who are seriously ill. It is not intended for children younger than the age set by the doctor, and the doctor will decide whether it is suitable. Ask the doctor or pharmacist if you are unsure why it has been prescribed.

How to use Sucralet

Take Sucralet 500 mg Tablet exactly as the doctor tells you. The doctor decides the dose, the timing of doses and how long the course lasts. Swallow the tablet as directed; ask the pharmacist if you are unsure how to take it. Do not change the dose or stop early on your own. If you also take other medicines, tell the doctor or pharmacist, as some medicines need to be spaced apart from sucralfate.

Side effects of Sucralet

Some people may notice headache, nausea, abdominal pain, constipation, diarrhoea or urticaria (hives). These are the events most often reported with sucralfate. Bezoars, which are clumps of material in the stomach, have mostly been reported in people with underlying conditions such as delayed gastric emptying or in those receiving tube feeding. Raised blood sugar has been reported in diabetic patients. Tell the doctor if you have troublesome symptoms.

Safety and precautions

Sucralfate has not been shown to be safe in pregnancy, so it should be used during pregnancy only if the doctor decides it is clearly needed. It is not known whether it passes into human breast milk, so breastfeeding women should ask the doctor before using it. Use with caution if you have kidney problems; it is not recommended for people on dialysis, and in severe or chronic kidney impairment it should be used with great care and only for short-term treatment. People allergic to sucralfate should not take it. Tell the doctor about all other medicines, because sucralfate can reduce how well some drugs are absorbed.

Frequently asked questions

Is Sucralet 500 mg Tablet safe during pregnancy or breastfeeding?

Safety in pregnancy has not been established, so it should be used only if the doctor decides it is clearly needed. It is not known whether sucralfate passes into breast milk, so breastfeeding women should ask the doctor before taking it.

What is Sucralet 500 mg Tablet used for and what kind of medicine is it?

It is a sucralfate tablet, a chelating complex that acts in the gut. It is used for duodenal ulcer, gastric ulcer, chronic gastritis, and to help prevent gastrointestinal bleeding from stress ulceration in seriously ill patients.

How should Sucralet 500 mg Tablet be stored?

Store it in a cool and dry place, protected from light. Keep it out of reach of children, and check with the pharmacist if you have any questions about storage or about a tablet that looks damaged.

Can Sucralet 500 mg Tablet affect other medicines?

Yes. Sucralfate can reduce the absorption of some medicines, including certain antibiotics, digoxin, warfarin, phenytoin, theophylline, levothyroxine and others. The doctor or pharmacist may advise separating the doses, so always tell them about every medicine you take.

Indications

Sucralfate is indicated in adults and adolescents over 14 years old for treatment of-
  • Duodenal ulcer
  • Gastric ulcer
  • Chronic gastritis
  • The prophylaxis of gastrointestinal hemorrhage from stress ulceration in seriously ill patients.

Pharmacology

Sucralfate is non-systemic as the drug is only minimally absorbed from the gastrointestinal tract. The minute amount which absorbed primarily excretes in the urine. Sucralfate promotes the healing of gastric and duodenal ulcers by the formation of a chemical complex that binds to the ulcer site to establish a protective barrier. Besides, Sucralfate inhibits the action of pepsin and bile.

Dosage & Administration

Duodenal ulcer, gastric ulcer, chronic gastritis-
  • Adults: The usual dose is Sucralfate 2 gm twice daily to be taken on rising and at bedtime or Sucralfate 1 gm four times a day to be taken 1 hour before meals and at bedtime. Maximum daily dose is 8 gm but up to twelve weeks may be necessary in resistant cases.
  • Pediatric population: The safety and efficacy of Sucralfate in children under 14 years of age has not been established.
  • Elderly: There are no special dosage requirements for elderly patients but as with all medicines the lowest effective dose should be used.
Prophylaxis of gastrointestinal hemorrhage from stress ulceration-
  • Adults: The usual dose is Sucralfate 1 gm orally or via a nasogastric tube 4 to 6 times a day. To prevent clogging of the nasogastric tube flush with 10 ml of water following each administration. The duration of treatment for prophylaxis of stress ulceration must be individually determined. Treatment should be continued for as long as one or more of the risk factors for stress ulceration is present but normally not for more than 14 days.

Interaction

Concomitant administration of Sucralfate may reduce the bioavailability of certain drugs including Fluoroquinolones such as Ciprofloxacin and Norfloxacin, Tetracycline, Ketoconazole, Sulpiride, Digoxin, Warfarin, Phenytoin, Theophylline, Levothyroxine, Quinidine, and H2 antagonists. The bioavailability of these agents may be restored by separating the administration of these agents from Sucralfate by two hours. This interaction appears to be non-systemic in origin presumably resulting from these agents being bound by Sucralfate in the gastrointestinal tract. Because of the potential of Sucralfate to alter the absorption of some drugs from the gastrointestinal tract, the separate administration of Sucralfate from that of other agents should be considered when alterations in bioavailability are felt to be critical for concomitantly administered drugs. Sucralfate should not be co-administered with citrate preparations. Co-administration citrate preparations with sucralfate may increase the blood concentrations of aluminium. The mechanism may be due to the chelation of aluminium which is assumed to increase its absorption. The administration of Sucralfate   1 g and enteral feeds by nasogastric tube should be separated by one hour in patients receiving Sucralfate 1 g for the prophylaxis of stress ulceration. In rare cases, bezoar formation has been reported when Sucralfate and enteral feeds have been given too closely together.

Contraindications

Sucralfate tablet and suspension are contraindicated in patients with hypersensitivity to sucralfate.

Side Effects

The most common adverse event was headache (3.4%) followed by nausea (2.3%), abdominal pain (2.3%), constipation (1.1%), diarrhea (1.1%), and urticaria (1.1%). The majority of patients who reported bezoars, had underlying medical conditions that may predispose to bezoar formation (such as delayed gastric emptying) or were receiving concomitant enteral tube feedings. Episodes of hyperglycemia have been reported in diabetic patient.

Pregnancy & Lactation

Safety in pregnant women has not been established and Sucralfate should be used during pregnancy only if clearly needed. It is not known whether this drug is excreted in human milk. Caution should be exercised when Sucralfate is administered to breast-feeding women.

Precautions & Warnings

Sucralfate should only be used with caution in patients with renal dysfunction, due to the possibility of increased aluminium absorption. Sucralfate is not recommended for use in individuals on dialysis. In patients with severe or chronic renal impairment, Sucralfate should be used with extreme caution and only for short-term treatment. Small amounts of aluminium are absorbed through the gastrointestinal tract and aluminium may accumulate. Aluminium osteodystrophy, osteomalacia, encephalopathy and anaemia have been reported in patients with chronic renal impairment. For patients with impairment of renal function, laboratory testing such as aluminium, phosphate, calcium and alkaline phosphatase is recommended to be periodically performed due to excretion impairment. The concomitant use of other aluminium containing medications is not recommended in view of the enhanced potential for aluminium absorption and toxicity. Bezoars have been reported after administration of sucralfate mainly to severely ill patients in intensive care units. The majority of these patients (including neonates in whom sucralfate is not recommended) had underlying conditions that may predispose to bezoar formation (such as delayed gastric emptying due to surgery, drug therapy or diseases that reduce motility) or were receiving concomitant enteral tube feeding.

Overdose Effects

In a clinical trial on healthy men of overdose with Sucralfate, most cases remained asymptomatic but symptoms of abdominal pain, nausea, and vomiting were reported in a few cases. Acute oral toxicity studies in animals using doses up to 12 gm/kg body weight could not find a lethal dose. Risks associated with overdose should therefore be minimal.

Storage Conditions

Store in a cool and dry place, protected from light.

Alternative brands of Sucralfate

Other brands with the same generic name, cheapest first.

Antepsin Tablet

1000 mg

Sucralfate

Kemiko Pharmaceuticals Ltd.

৳ 5.41 ৳ 5.52 2% off per unit

Ulsec Tablet

1 gm

Sucralfate

Asiatic Laboratories Ltd.

৳ 5.88 ৳ 6.00 2% off per unit

See all 15 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.